Cipta Sarana Medika Tbk. vs Super Bank Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while Super Bank Indonesia Tbk. trades at Rp585 (market cap 19.46T, 10.03M 24h volume). The key difference: Super Bank Indonesia Tbk. is far larger — about 123.1× Cipta Sarana Medika Tbk.'s market cap, and Super Bank Indonesia Tbk. is more actively traded (10.03M versus 8.21M). Which is the better fit depends on your goals.
| DKHH | SUPA | |
|---|---|---|
Market Cap | 158.12B | 19.46T |
Volume | 8.21M | 10.03M |
Lot | 82.15K | 100.32K |
Turnover | 515.2M | 5.86B |
Average Price | 62.72 | 584.5 |
Value | 515.2M | 5.86B |
Indicative Equilibrium Price | 63 | 585 |
Indicative Equilibrium Volume | 1.33K | 2.54K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Super Bank Indonesia Tbk. (hereinafter referred to as the Bank) formerly under the name of PT Bank Fama International was established by Deed No. 36 on 5 March 1993, before Notary Herlien, S.H. The Bank has received a license as a commercial bank according to the Decree of the Minister of Finance of the Republic of Indonesia No. 834/KMK.017/1993 dated 11 October 1993.
Read more on SUPA →